| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| HDFC Pharma and Healthcare Fund (G) Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.25 |
| Equity |
98.42 |
| Trep |
1.83 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
30.66% |
| Top 10 Holdings |
48.86% |
| Top 25 Holdings |
84.39% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
72.12 |
| Healthcare |
26.3 |
| Cash |
1.58 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
6.64 |
| PE Ratio |
50.42 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Divis Laboratories Ltd. |
9.54 |
| Sun Pharmaceutical Industries Ltd. |
8.94 |
| Torrent Pharmaceuticals Ltd. |
4.08 |
| Max Healthcare Institute Limited |
4.06 |
| Lupin Ltd |
4.04 |
| Cipla Ltd. |
3.94 |
| Aster DM Healthcare Limited |
3.84 |
| Neuland Laboratories Limited. |
3.70 |
| Anthem Biosciences Limited |
3.48 |
| ACUTAAS CHEMICALS LIMITED |
3.24 |
| Ipca Laboratories Ltd. |
3.23 |
| Shilpa Medicare Ltd. |
3.10 |
| Alkem Laboratories Limited |
3.06 |
| Global Health Limited |
2.85 |
| RUBICON RESEARCH LIMITED |
2.82 |
| Fortis Healthcare Ltd |
2.37 |
| Glenmark Pharmaceuticals ltd |
2.34 |
| Krishna Institute of Medical Sciences Limited |
2.25 |
| Vijaya Diagnostic Centre Limited |
2.24 |
| EQ- JUPITER LIFE LINE HOSPITALS LTD |
1.94 |
| Zydus Lifesciences Limited |
1.93 |
| Metropolis Healthcare Limited |
1.90 |
| Dr. Reddys Laboratories Ltd. |
1.90 |
| TREPS - Tri-party Repo |
1.83 |
| Molbio Diagnostics Limited |
1.77 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|